Sign in
4

Changes in Ownership

Atara Biotherapeutics, Inc. Filed Acc 0001209191-17-033914

Chief Executive Officer sold 4,800 shares at an average $14.91 ($71,568)

From the SEC's structured data for this filing

Trades in this filing

Ciechanover Isaac E. · Chief Executive Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2017-05-17 Sale : show line 1 in the form −2,400 $14.88 $35,712 465,378 I
2017-05-18 Sale : show line 2 in the form −2,400 $14.94 $35,856 462,978 I
Open-market sales · 4,800 sh · avg $14.91 · $71,568
Loading xslF345X03/doc4.xml…